CastleKnight Management LP Sells 158,886 Shares of Phibro Animal Health Corporation $PAHC

CastleKnight Management LP trimmed its holdings in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 39.7% during the 4th quarter, Holdings Channel reports. The fund owned 240,897 shares of the company’s stock after selling 158,886 shares during the period. CastleKnight Management LP’s holdings in Phibro Animal Health were worth $9,000,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in Phibro Animal Health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 1,539,593 shares of the company’s stock worth $57,519,000 after acquiring an additional 13,884 shares in the last quarter. State Street Corp grew its holdings in Phibro Animal Health by 5.4% during the 4th quarter. State Street Corp now owns 942,279 shares of the company’s stock worth $35,204,000 after acquiring an additional 48,243 shares in the last quarter. Geode Capital Management LLC grew its holdings in Phibro Animal Health by 4.0% during the 4th quarter. Geode Capital Management LLC now owns 569,111 shares of the company’s stock worth $21,265,000 after acquiring an additional 21,951 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Phibro Animal Health by 1.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 492,335 shares of the company’s stock worth $18,394,000 after acquiring an additional 6,826 shares in the last quarter. Finally, Millennium Management LLC grew its holdings in Phibro Animal Health by 74.3% during the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock worth $7,733,000 after acquiring an additional 154,281 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Weiss Ratings cut shares of Phibro Animal Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday. Citigroup dropped their target price on shares of Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating on the stock in a report on Thursday, May 14th. Zacks Research lowered shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 21st. Finally, Wall Street Zen lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $42.50.

Phibro Animal Health Stock Performance

PAHC stock opened at $30.84 on Thursday. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of 13.24, a PEG ratio of 0.48 and a beta of 0.46. The firm has a 50-day simple moving average of $42.46 and a two-hundred day simple moving average of $44.53. Phibro Animal Health Corporation has a one year low of $23.57 and a one year high of $60.08. The company has a debt-to-equity ratio of 1.97, a quick ratio of 1.26 and a current ratio of 3.17.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.72 by $0.04. The business had revenue of $383.54 million during the quarter, compared to analyst estimates of $367.02 million. Phibro Animal Health had a net margin of 6.35% and a return on equity of 37.14%. Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. On average, equities analysts forecast that Phibro Animal Health Corporation will post 3.08 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 24th. Shareholders of record on Wednesday, June 3rd will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Wednesday, June 3rd. Phibro Animal Health’s dividend payout ratio is presently 20.60%.

Insider Activity at Phibro Animal Health

In other Phibro Animal Health news, CEO Jack Bendheim sold 4,528 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $48.49, for a total transaction of $219,562.72. Following the completion of the sale, the chief executive officer directly owned 56,152 shares of the company’s stock, valued at approximately $2,722,810.48. This represents a 7.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 46,768 shares of company stock worth $2,560,222 over the last ninety days. Corporate insiders own 50.13% of the company’s stock.

Phibro Animal Health Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.